JUAN JOSÉ LAHUERTA-PALACIOS; SANTIAGO LARREGLA-GARRAUS; FRANCISCO FERNÁNDEZ-DEBORA; RICARDO RUIZ DE ADANA
To the editor: Barton and Conrad reported in the February 1979 issue (1) an association of elevation of the aspartate transaminase (AST) levels with improved prognosis of acute myelogenous leukemia. Further data confirming this observation are scarce (2-4), although 2 years have elapsed since it was described.
We wish to point out a critical defect in the studies that have been carried out: The AST level is considered to be the only factor that influences the prognosis. At the time of diagnosis and during the "induction phase" of acute myelogenous leukemia, there are additional simultaneous prognostic factors: classification, previous or
Learn more about subscription options.
Register Now for a free account.
LAHUERTA-PALACIOS JJ, LARREGLA-GARRAUS S, FERNÁNDEZ-DEBORA F, RUIZ DE ADANA R. Prognosis of Acute Myelogenous Leukemia. Ann Intern Med. 1982;97:140. doi: 10.7326/0003-4819-97-1-140_1
Download citation file:
Published: Ann Intern Med. 1982;97(1):140.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only